Creative Planning’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$171K Buy
19,376
+1,759
+10% +$15.6K ﹤0.01% 3271
2025
Q1
$138K Buy
17,617
+17,467
+11,645% +$137K ﹤0.01% 3172
2024
Q4
$1.58K Sell
150
-12,231
-99% -$129K ﹤0.01% 3462
2024
Q3
$162K Buy
12,381
+938
+8% +$12.3K ﹤0.01% 2907
2024
Q2
$161K Hold
11,443
﹤0.01% 2723
2024
Q1
$193K Sell
11,443
-6,359
-36% -$107K ﹤0.01% 2566
2023
Q4
$251K Sell
17,802
-1,676
-9% -$23.7K ﹤0.01% 2220
2023
Q3
$201K Buy
19,478
+438
+2% +$4.51K ﹤0.01% 2230
2023
Q2
$314K Buy
19,040
+584
+3% +$9.62K ﹤0.01% 1872
2023
Q1
$169K Buy
18,456
+849
+5% +$7.78K ﹤0.01% 2161
2022
Q4
$126K Buy
17,607
+543
+3% +$3.89K ﹤0.01% 2107
2022
Q3
$85K Buy
17,064
+1,277
+8% +$6.36K ﹤0.01% 2033
2022
Q2
$39K Buy
15,787
+2,083
+15% +$5.15K ﹤0.01% 2059
2022
Q1
$94K Buy
13,704
+2,353
+21% +$16.1K ﹤0.01% 1989
2021
Q4
$92K Buy
+11,351
New +$92K ﹤0.01% 1962
2021
Q2
Sell
-15,700
Closed -$142K 2015
2021
Q1
$142K Hold
15,700
﹤0.01% 2133
2020
Q4
$105K Buy
+15,700
New +$105K ﹤0.01% 1963
2017
Q2
Sell
-3,000
Closed -$29K 4483
2017
Q1
$29K Buy
3,000
+1,000
+50% +$9.67K ﹤0.01% 2829
2016
Q4
$21K Hold
2,000
﹤0.01% 3005
2016
Q3
$25K Hold
2,000
﹤0.01% 2862
2016
Q2
$21K Sell
2,000
-2,500
-56% -$26.3K ﹤0.01% 2721
2016
Q1
$50K Sell
4,500
-1,350
-23% -$15K ﹤0.01% 2093
2015
Q4
$71K Buy
5,850
+350
+6% +$4.25K ﹤0.01% 1819
2015
Q3
$90K Buy
+5,500
New +$90K ﹤0.01% 1637
2015
Q2
Sell
-5,500
Closed -$99K 1193
2015
Q1
$99K Buy
5,500
+5,000
+1,000% +$90K ﹤0.01% 1563
2014
Q4
$9K Buy
+500
New +$9K ﹤0.01% 3119
2014
Q2
Sell
-13,460
Closed -$180K 3638
2014
Q1
$180K Buy
+13,460
New +$180K ﹤0.01% 1049